Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enke Baldini

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Plos One|March 26, 2015
Deregulated expression of Aurora kinases is not a prognostic biomarker in papillary thyroid cancer patientsEnke Baldini, Chiara Tuccilli, Natalie Prinzi, et al.
International Journal of Molecular Sciences|January 23, 2024
Evaluation of the Therapeutic Effects of Harmine on Anaplastic Thyroid Cancer CellsEnke Baldini, Silvia Cardarelli, Antonio Francesco Campese, et al.
Journal of Clinical Medicine|March 29, 2023
Insights on the Association between Thyroid Diseases and Colorectal CancerFederica Gagliardi, Enke Baldini, Eleonora Lori, et al.
Oncology Reports|March 9, 2018
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivoSilvia Martina Ferrari, Guido Bocci, Teresa Di Desidero, et al.
International Journal of Molecular Sciences|April 12, 2022
In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell LinesEnke Baldini, Dario Presutti, Pasqualino Favoriti, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 13, 2018
Iodine deficiency in pregnancy: Still a health issue for the women of Cassino city, ItalyChiara Tuccilli, Enke Baldini, Elia Truppa, et al.
Cancers|December 9, 2020
Evaluation of Clinicopathological and Molecular Parameters on Disease Recurrence of Papillary Thyroid Cancer Patient: A Retrospective Observational StudySalvatore Sorrenti, Giovanni Carbotta, Filippo Maria Di Matteo, et al.
Oncology Reports|March 9, 2018
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivoSilvia Martina Ferrari, Guido Bocci, Teresa Di Desidero, et al.
International Journal of Oncology|March 29, 2017
Expression and prognostic value of the cell polarity PAR complex members in thyroid cancerChiara Tuccilli, Enke Baldini, Yannick Arlot-Bonnemains, et al.
The British Journal of Dermatology|May 31, 2024
Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosaAlessia Primerano, Emanuela De Domenico, Francesca Cianfarani, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Plos One|March 26, 2015
Deregulated expression of Aurora kinases is not a prognostic biomarker in papillary thyroid cancer patientsEnke Baldini, Chiara Tuccilli, Natalie Prinzi, et al.
International Journal of Molecular Sciences|January 23, 2024
Evaluation of the Therapeutic Effects of Harmine on Anaplastic Thyroid Cancer CellsEnke Baldini, Silvia Cardarelli, Antonio Francesco Campese, et al.
Journal of Clinical Medicine|March 29, 2023
Insights on the Association between Thyroid Diseases and Colorectal CancerFederica Gagliardi, Enke Baldini, Eleonora Lori, et al.
Oncology Reports|March 9, 2018
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivoSilvia Martina Ferrari, Guido Bocci, Teresa Di Desidero, et al.
International Journal of Molecular Sciences|April 12, 2022
In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell LinesEnke Baldini, Dario Presutti, Pasqualino Favoriti, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 13, 2018
Iodine deficiency in pregnancy: Still a health issue for the women of Cassino city, ItalyChiara Tuccilli, Enke Baldini, Elia Truppa, et al.
Cancers|December 9, 2020
Evaluation of Clinicopathological and Molecular Parameters on Disease Recurrence of Papillary Thyroid Cancer Patient: A Retrospective Observational StudySalvatore Sorrenti, Giovanni Carbotta, Filippo Maria Di Matteo, et al.
Oncology Reports|March 9, 2018
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivoSilvia Martina Ferrari, Guido Bocci, Teresa Di Desidero, et al.
International Journal of Oncology|March 29, 2017
Expression and prognostic value of the cell polarity PAR complex members in thyroid cancerChiara Tuccilli, Enke Baldini, Yannick Arlot-Bonnemains, et al.
The British Journal of Dermatology|May 31, 2024
Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosaAlessia Primerano, Emanuela De Domenico, Francesca Cianfarani, et al.
Pageof 8